FDA Drug Application (020699) for EFFEXOR XR by WYETH PHARMS INC

Back to FDA Applications sponsored by WYETH PHARMS INC

Application Number020699
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
DosageEQ 37.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEFFEXOR XR
Active IngredientVENLAFAXINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient VENLAFAXINE HYDROCHLORIDE3


Back to FDA Applications sponsored by WYETH PHARMS INC